Friday, 20 Oct 2017

You are here

22 September 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report discusses survey results on membranous nephritis and patient perceptions of steroids, nonadherence, celebrity arthritis and IgG4 treatment. 

  1. Framingham foot study- those with B/L foot pain have increased odds of knee & hip pain (males and females); ipsilateral foot & hip pain more in men https://t.co/ky2zlL5Dsl
  2. Survey of glucocorticoid users: "steroids help alot" wherein the benefits outweigh adverse events. Yet AEs more common with GC use -thin skin, bruising, poor sleep, altered mood & moon face https://t.co/NZi5xn6cR4.
  3. Astounding! Drug nonadherence is as high as 74% in AS, 90% in gout, 50% in PsA, 75% in SLE, 82% in RA https://t.co/eP5yyf996e 
  4. Statin use not assoc. w/ lupus in adults >40yrs; >1 yr of statin use has a 38% lower risk of developing SLE https://t.co/rBJiPKiIZK
  5. Retrospective review of 464 Polyarticular vs 42 Monarticular Septic arthritis: Many outcomes similar but Polyarticular septic Arthritis were more likely to have preexisting RA, higher SF WBC, longer hospital stays https://t.co/mPgFw13dpo
  6. Survey of pediatric Rheums vs nephrologists showed nephrologists use less steroids (60% vs 93%) & MMF (53 vs 87%) than Rheums for management of membranous lupus nephritis without nephrotic syndrome. https://t.co/HxT63C7WGV
  7. RA patients with fibromyalgia (17%) were unlikely to achieve SDAI remission, more pain/comorbidity, worse sleep, higher SF36 MCS https://t.co/E7n0qjVNap  
  8. 50 pt trial of steroid injections vs wrist splinting for carpal tunnel syndrome shows injections with better dexterity, and patient satisfaction https://t.co/0gaYCURTOR
  9. Selena Gomez recovering from renal transplant due to her Lupus. https://t.co/KtkEIFj8nT
  10. Lady Gaga has Fibromyalgia. She intends to shine the light on FM in a Netflix documentary "Lady Gaga:Five Foot Two" https://t.co/Z91zU1kcRk
  11. Mortality with Interstitial Lung Disease in Rheumatoid Arthritis. http://rheumnow.com/content/mortality-interstitial-lung-disease-rheumato...
  12. Romosuzumab Followed by Alendronate is Best in Fracture Prevention http://rheumnow.com/content/romosuzumab-followed-alendronate-best-fractu...
  13. Rituximab Efficacy in IgG4 Related Disease http://rheumnow.com/content/rituximab-efficacy-igg4-related-disease
Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

13 October 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. In this week's report, Dr. Jack Cush discusses a novel antiviral drug or the use of stem cell therapy for scleroderma, rituximab in HSP, when to withdraw NSAIDS in RA, and congrats to PAs and NPs!

The Big Need - NPs and PAs

Despite being one of the most satisfying of medical subspecialties, the number of U.S. rheumatologists is about to sharply decline.  These data were presented at the 2016 ACR meeting, where it was shown that the estimated total number of U.S. rheumatologists in in 2015 was 4,933 and is projected decrease to 3,645 by 2025. During this declining clinical supply, there will be a 138% increase in demand from 6,155 to 8,184 by 2030.

Arthritis Burden over $303 Billion Annually in U.S.

Arthritis of all types in the U.S. carried an economic burden of $303.5 billion in 2013, nearly 1% of the gross domestic product that year, according to a CDC analysis.

The RheumNow Week in Review - 6 October 2017

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. In this week's report, Dr. Jack Cush discusses when to hold the biologic, lymphoma risk with tofacitinib, early clues to the diagnosis of RA, biologic use in pregnancy, what's killing psoriasis patients and the 2016 top 5, best selling drugs in rheumatology.

29 September 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report discusses regulatory actions by NICE and FDA, higher death rates in RA and psoriasis, increased risk of RA with Asthma, rising numbers for OA, RA, and STDs.